ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 172 filers reported holding ACCELERON PHARMA INC in Q3 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $5,531,000 | -88.5% | 58,056 | -89.2% | 0.44% | -91.2% |
Q1 2020 | $48,137,000 | -9.2% | 535,627 | -46.4% | 5.03% | +8.9% |
Q4 2019 | $53,020,000 | -7.8% | 1,000,000 | -31.3% | 4.62% | -12.6% |
Q3 2019 | $57,475,000 | -99.9% | 1,454,700 | +0.4% | 5.28% | -20.1% |
Q2 2019 | $59,537,000,000 | +118261.5% | 1,449,300 | +34.2% | 6.61% | +32.7% |
Q1 2019 | $50,301,000 | +11.4% | 1,080,113 | +4.2% | 4.98% | -12.7% |
Q4 2018 | $45,143,000 | -14.1% | 1,036,575 | +12.9% | 5.71% | -30.3% |
Q3 2018 | $52,524,000 | -23.7% | 917,767 | -35.3% | 8.19% | -14.2% |
Q2 2018 | $68,811,000 | -99.6% | 1,418,200 | +206.8% | 9.54% | +255.3% |
Q1 2018 | $18,074,000,000 | +245905.2% | 462,245 | +167.0% | 2.68% | +114.0% |
Q4 2017 | $7,347,000 | +15.8% | 173,124 | +1.8% | 1.25% | +1.6% |
Q3 2017 | $6,344,000 | -57.7% | 170,000 | -65.6% | 1.23% | -54.1% |
Q2 2017 | $14,997,000 | +88.9% | 493,500 | +64.5% | 2.69% | +70.4% |
Q1 2017 | $7,941,000 | – | 300,000 | – | 1.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |